A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Rafiq, Sajjad ^a   Khan, Sofia ^d   Tapper, William ^a   Collins, Andrew ^a   Upstill Goddard, Rosanna ^a   Gerty, Susan ^b   Blomqvist, Carl ^e   Aittomäki, Kristiina ^e   Couch, Fergus J ^c   Liu, Jianjun ^f   Nevanlinna, Heli ^d   Eccles, Diana ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARRDC3 GENE; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; COHORT ANALYSIS; ECHDC3 GENE; FEMALE; FOXF1 GENE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LINC00917 GENE; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROSER2 GENE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; AGED; BREAST NEOPLASMS; CASE CONTROL STUDY; GENE LOCUS; GENETICS; META ANALYSIS; MIDDLE AGED; PROGNOSIS;

ARRDC3 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXF1 PROTEIN, HUMAN; RETINA S ANTIGEN;

ADULT; AGED; ARRESTINS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 84919617697     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101488     Document Type: Article

References (43)

1. Office for national statistics website. Available: http://www.statistics.gov.uk/hub/index.html. Acessed 2014 Mar 17.
2. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
3. Buyse M, Loi S, van't Veer L, Viale G, Delorenzi M, et al. (2006) Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. Journal of the National Cancer Institute 98: 1183-1192.
4. Paik S, Shak S, Tang G, Kim C, Baker J, et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817-2826.
5. Sotiriou C and Pusztai L (2009) Gene-expression signatures in breast cancer. N Engl J Med 360: 790-800.
6. Lindstrom LS, Hall P, Hartman M, Wiklund F, Gronberg H, et al. (2007) Familial concordance in cancer survival: a Swedish population-based study. Lancet Oncol 8: 1001-1006.
7. Hartman M, Lindstrom L, Dickman PW, Adami HO, Hall P, et al. (2007) Is breast cancer prognosis inherited. Breast Cancer Res Tr 9.
8. Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, et al. (2005) Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11: 5175-5180.
9. Wilson JR, Bateman AC, Hanson H, An Q, Evans G, et al. (2010) A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations. J Med Genet 47: 771-774.
10. Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, et al. (2013) Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 45: 392-398, 398e391-392.
11. Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, et al. (2011) A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet 43: 1210-1214.
12. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, et al. (2008) Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 40: 703-706.
13. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, et al. (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39: 865-869.
14. Chen W, Zhong R, Ming J, Zou L, Zhu B, et al. (2012) The SLC4A7 variant rs4973768 is associated with breast cancer risk: evidence from a case-control study and a meta-analysis. Breast Cancer Res Treat 136: 847-857.
15. Azzato EM, Pharoah PD, Harrington P, Easton DF, Greenberg D, et al. (2010) A genome-wide association study of prognosis in breast cancer. Cancer Epidemiol Biomarkers Prev 19: 1140-1143.
16. Fasching PA, Pharoah PD, Cox A, Nevanlinna H, Bojesen SE, et al. (2012) The role of genetic breast cancer susceptibility variants as prognostic factors. Hum Mol Genet 21: 3926-3939.
17. Azzato EM, Tyrer J, Fasching PA, Beckmann MW, Ekici AB, et al. (2010) Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. J Natl Cancer Inst 102: 650-662.
18. Shu XO, Long J, Lu W, Li C, Chen WY, et al. (2012) Novel genetic markers of breast cancer survival identified by a genome-wide association study. Cancer Res 72: 1182-1189.
19. Rafiq S, Tapper W, Collins A, Khan S, Politopoulos I, et al. (2013) Identification of inherited genetic variations influencing prognosis in early-onset breast cancer. Cancer Res 73: 1883-1891.
20. Eccles D, Gerty S, Simmonds P, Hammond V, Ennis S, et al. (2007) Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocol. BMC Cancer 7: 160.
21. Fagerholm R, Hofstetter B, Tommiska J, Aaltonen K, Vrtel R, et al. (2008) NAD(P)H: quinone oxidoreductase 1 NQO1∗2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. Nature genetics 40: 844-853.
22. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, et al. (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. Nature genetics 42: 504-507.
23. Rafiq S, Tapper W, Collins A, Khan S, Politopoulos I, et al. (2013) Identification of inherited genetic variations influencing prognosis in early onset breast cancer. Cancer research.
24. Li J, Humphreys K, Heikkinen T, Aittomaki K, Blomqvist C, et al. (2011) A combined analysis of genome-wide association studies in breast cancer. Breast Cancer Res Treat 126: 717-727.
25. (2003) The International HapMap Project. Nature 426: 789-796. genabel website. Available: http://www.genabel.org/. Accessed 2013 Dec 9.
26. Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altman DG, et al. (2008) metan: fixed- and random-effects meta-analysis. Stata Journal 8: 3-28.
27. Downey L, Livingston RB, Koehler M, Arbushites M, Williams L, et al. (2010) Chromosome 17 polysomy without human epidermal growth factor receptor 2 amplification does not predict response to lapatinib plus paclitaxel compared with paclitaxel in metastatic breast cancer. Clin Cancer Res 16: 1281-1288.
28. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, et al. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26: 2336-2337.
29. Nica AC, Parts L, Glass D, Nisbet J, Barrett A, et al. (2011) The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS genetics 7: e1002003. scandb Website. Available: http://www.scandb.org/newinterface/about.html. Accessed 2013 Dec 9.
30. Gamazon ER, Zhang W, Konkashbaev A, Duan S, Kistner EO, et al. (2010) SCAN: SNP and copy number annotation. Bioinformatics 26: 259-262.
31. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, et al. (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942.
32. Hashimoto T, Shindo Y, Souri M and Baldwin GS (1996) A new inhibitor of mitochondrial fatty acid oxidation. J Biochem 119: 1196-1201.
33. Herschkowitz JI, Zhao W, Zhang M, Usary J, Murrow G, et al. (2012) Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. Proceedings of the National Academy of Sciences of the United States of America 109: 2778-2783.
34. Silbiger VN, Luchessi AD, Hirata RD, Lima-Neto LG, Cavichioli D, et al. (2013) Novel genes detected by transcriptional profiling from whole-blood cells in patients with early onset of acute coronary syndrome. Clin Chim Acta 421: 184-190.
35. Lykke-Andersen J, Shu MD, Steitz JA (2000) Human Upf proteins target an mRNA for nonsense-mediated decay when bound downstream of a termination codon. Cell 103: 1121-1131.
36. Lincoln DW, 2nd and Bove K (2005) The transcription factor Ets-1 in breast cancer. Front Biosci 10: 506-511.
37. Verschoor ML, Wilson LA, Singh G (2010) Mechanisms associated with mitochondrial-generated reactive oxygen species in cancer. Can J Physiol Pharmacol 88: 204-219.
38. Buggy Y, Maguire TM, McGreal G, McDermott E, Hill AD, et al. (2004) Overexpression of the Ets-1 transcription factor in human breast cancer. Br J Cancer 91: 1308-1315.
39. Levine DM, Ek WE, Zhang R, Liu X, Onstad L, et al. (2013) A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet 45: 1487-1493.
40. Lincoln DW 2nd, Bove K (2005) The transcription factor Ets-1 in breast cancer. Front Biosci 10: 506-511.
41. Verschoor ML, Wilson LA, Singh G (2010) Mechanisms associated with mitochondrial-generated reactive oxygen species in cancer. Can J Physiol Pharmacol 88: 204-219.
42. Buggy Y, Maguire TM, McGreal G, McDermott E, Hill AD, et al. (2004) Overexpression of the Ets-1 transcription factor in human breast cancer. Br J Cancer 91: 1308-1315.
43. Levine DM, Ek WE, Zhang R, Liu X, Onstad L, et al. (2013) A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet 45: 1487-1493.